The document recommends buying shares of Indoco Remedies Ltd, an Indian pharmaceutical company, with the expectation that the stock price will rise 17.8% over the next 90 days. It provides financial data for Indoco showing increasing quarterly revenues and profits. The recommendation is based on Indoco's strong financial performance and technical analysis showing the stock price is currently below resistance levels, indicating further upside potential. However, investors are advised to make independent decisions as the recommendation does not guarantee investment results.

1. BUY TO SELL STOCKS FOR SHORT TERM GAINS
11th
JANUARY 2015
INDOCO REMEDIES LTD BUY POTENTIAL UPSIDE: 17.8%
CURRENT MARKET PRICE: 326.95 TARGET PRICE: 385.00
BSE Code 532612 Market Cap (Millions) 30128.56
NSE Code INDOCO P/E 40.11
Book Value 53.80 EPS 8.15
Face Value 2 Dividend Yield % 0.43
STOCK RECOMMENDATION

2. 15% @ 90 DAYS – JANUARY 2015
- 2 - SARAL GYAN CAPITAL SERVICES
Comparative Chart (Last 1 Year)
Returns: Indoco Remedies & Nifty:
Nifty: 32% Indoco Remedies: 155%
Stock Resistance and Support:
1st
Resistance – 345 1st
Support – 315
2nd
Resistance – 370 2nd
Support – 290

3. 15% @ 90 DAYS – JANUARY 2015
- 3 - SARAL GYAN CAPITAL SERVICES
Financials at a Glance:
Quarterly Results of Indoco Remedies Ltd (Rs. In Millions)
Particulars Sep 2014 Jun 2014 Mar 2014 Dec 2013
Audited / UnAudited UnAudited UnAudited UnAudited UnAudited
Net Sales 2284.30 1986.30 1836.20 1878.10
Total Expenditure 1798.00 1620.60 1507.60 1579.60
PBIDT (Excl OI) 486.30 365.70 328.60 298.50
Other Income 5.60 6.20 10.20 1.10
Operating Profit 491.90 371.90 338.80 299.60
Interest 26.80 27.30 34.50 38.60
Exceptional Items 0 0 0 0
PBDT 465.10 344.60 304.30 261.00
Depreciation 131.50 94.70 78.50 80.20
Profit Before Tax 333.60 249.90 225.80 180.80
Tax 109.50 49.50 40.30 39.60
Provisions and contingencies 0 0 0 0
Profit After Tax 224.10 200.40 185.50 141.20
Extraordinary Items 0 0 0 0
Prior Period Expenses 0 0 0 0
Other Adjustments 0 0 0 0
Net Profit 224.10 200.40 185.50 141.20
Equity Capital 184.30 184.30 184.30 184.30
Face Value (IN RS) 2 2 2 2
Reserves
Calculated EPS 2.43 2.17 2.01 1.53
Calculated EPS (Annualised) 9.73 8.70 8.05 6.13
No of Public Share Holdings 37552721.00 37601399.00 37601399.00 37578444.00
% of Public Share Holdings 40.75 40.80 40.80 40.78

4. 15% @ 90 DAYS – JANUARY 2015
- 4 - SARAL GYAN CAPITAL SERVICES
Basis of Recommendation:
i) Technical Analysis
Disclaimer:
Important Notice: Saral Gyan Capital Services is an Independent Equity Research Company.
© SARAL GYAN CAPITAL SERVICES
This Service is provided on an "As Is" basis by saral gyan capital services. Saral gyan capital
services and its affiliates disclaim any warranty of any kind, imputed by the laws of any
jurisdiction, whether express or implied, as to any matter whatsoever relating to the Service,
including without limitation the implied warranties of merchantability, fitness for a particular
purpose. Neither saral gyan capital services nor its affiliates will be responsible for any loss or
liability incurred to the user as a consequence of his or any other person on his behalf taking any
investment decisions based on the above recommendation. Use of the Service is at any persons,
including a Customer's, own risk. The investments discussed or recommended through this
service may not be suitable for all investors. Investors must make their own investment decisions
based on their specific investment objectives and financial position and using such independent
advisors as they believe necessary. Information herein is believed to be reliable but saral gyan
capital services and its affiliates do not warrant its completeness or accuracy. The service should
not be construed to be an advertisement for solicitation for buying or selling of any securities.